Evaluation and multi-institutional validation of a novel urine biomarker lncRNA546 to improve the diagnostic specificity of prostate cancer in PSA gray-zone

BACKGROUND AND OBJECTIVES: Prostate specific antigen (PSA) is currently the most commonly used biomarker for prostate cancer diagnosis. However, when PSA is in the gray area of 4-10 ng/ml, the diagnostic specificity of prostate cancer is extremely low, leading to overdiagnosis in many clinically fal...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Fei, Shi, Xiaolei, Wang, Fangming, Han, Sujun, Chen, Dong, Gao, Xu, Wang, Linhui, Wei, Qiang, Xing, Nianzeng, Ren, Shancheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411806/
https://www.ncbi.nlm.nih.gov/pubmed/36033474
http://dx.doi.org/10.3389/fonc.2022.946060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411806/
https://www.ncbi.nlm.nih.gov/pubmed/36033474
http://dx.doi.org/10.3389/fonc.2022.946060

Ejemplares similares